Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Latest filing published 23 Jan 2026 for Acumen Pharmaceuticals, Inc., €3,585. Read the official filing
Filing timeline
BuySaleEric Siemers
Insider track record
Disclosed buys
0
Disclosed sells
5
Signal history
Eric Siemers: trading record in brief
Eric Siemers is a declared insider of Acumen Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 17 January 2023 to 21 January 2026.
Every open-market trade on record is a sale: 5 sales worth €45k. Other entries cover 4 share grants. Since January 2026: no purchases and 2 sales on the market.
The newest entry dates from 23 January 2026: an open-market sale of €3,585, in Acumen Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric Siemers
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
2,331 shares@ US$1.80357.9% of flowCommon StockSEC:0001628280-26-003348:0
99,133 shares0Common StockSEC:0001628280-26-002959:0
4,000 shares@ US$1.958714.8% of flowCommon StockSEC:0001628280-26-001264:0
3,219 shares@ US$1.5910.8% of flowCommon StockSEC:0001576885-25-000029:0
66,800 shares0Common StockSEC:0001576885-25-000009:1
10,859 shares@ US$1.846143.0% of flowCommon StockSEC:0001576885-25-000009:0
3,124 shares@ US$3.714423.5% of flowCommon StockSEC:0001576885-24-000025:0
94,000 shares0Common StockSEC:0001576885-24-000011:0
26,700 shares0Common StockSEC:0001209191-23-003745:0
9 of 9 declarations
